Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Whitney Barham

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cancers|May 2, 2018
Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes?Brooke D Paradise, Whitney Barham, Martín E Fernandez-Zapico
Molecular Cancer|November 11, 2015
Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancerAndrew J Wilson, Jeanette Saskowski, Whitney Barham, et al.
Journal of Ovarian Research|July 29, 2015
Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancerAndrew J Wilson, Jeanette Saskowski, Whitney Barham, et al.
Genes & Diseases|February 12, 2020
Paradox-driven adventures in the development of cancer immunology and immunotherapyWhitney Barham, Joanina K Gicobi, Yiyi Yan, et al.
Journal of Visualized Experiments : Jove|September 14, 2012
Intraductal injection of LPS as a mouse model of mastitis: signaling visualized via an NF-κB reporter transgenicWhitney Barham, Taylor Sherrill, Linda Connelly, et al.
Frontiers in Immunology|February 19, 2021
Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor TherapyWhitney Barham, Ruifeng Guo, Sean S Park, et al.
International Journal of Nanomedicine|June 9, 2016
Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functionsRyan A Ortega, Whitney Barham, Kavya Sharman, et al.
Journal of Ovarian Research|September 12, 2013
Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse modelAndrew J Wilson, Whitney Barham, Jeanette Saskowski, et al.
BMC Cancer|October 2, 2015
Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situWhitney Barham, Lianyi Chen, Oleg Tikhomirov, et al.
Nuclear Medicine and Biology|June 13, 2021
Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor modelAditya Bansal, Mukesh K Pandey, Whitney Barham, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cancers|May 2, 2018
Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes?Brooke D Paradise, Whitney Barham, Martín E Fernandez-Zapico
Molecular Cancer|November 11, 2015
Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancerAndrew J Wilson, Jeanette Saskowski, Whitney Barham, et al.
Journal of Ovarian Research|July 29, 2015
Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancerAndrew J Wilson, Jeanette Saskowski, Whitney Barham, et al.
Genes & Diseases|February 12, 2020
Paradox-driven adventures in the development of cancer immunology and immunotherapyWhitney Barham, Joanina K Gicobi, Yiyi Yan, et al.
Journal of Visualized Experiments : Jove|September 14, 2012
Intraductal injection of LPS as a mouse model of mastitis: signaling visualized via an NF-κB reporter transgenicWhitney Barham, Taylor Sherrill, Linda Connelly, et al.
Frontiers in Immunology|February 19, 2021
Case Report: Simultaneous Hyperprogression and Fulminant Myocarditis in a Patient With Advanced Melanoma Following Treatment With Immune Checkpoint Inhibitor TherapyWhitney Barham, Ruifeng Guo, Sean S Park, et al.
International Journal of Nanomedicine|June 9, 2016
Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functionsRyan A Ortega, Whitney Barham, Kavya Sharman, et al.
Journal of Ovarian Research|September 12, 2013
Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse modelAndrew J Wilson, Whitney Barham, Jeanette Saskowski, et al.
BMC Cancer|October 2, 2015
Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situWhitney Barham, Lianyi Chen, Oleg Tikhomirov, et al.
Nuclear Medicine and Biology|June 13, 2021
Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor modelAditya Bansal, Mukesh K Pandey, Whitney Barham, et al.
Pageof 3